Friday, May 1, 2026

Kim Jong Un Visits Grandfather’s Tomb to Mark 31 Years Since His Death

Kim Jong Un commemorates Kim Il Sung's death anniversary at Kumsusan Palace, affirming his predecessors' legacy amidst national remembrance.

North Korea Mobilizes Youth to Rebuild Flood-Damaged Areas in North Pyongan Province

North Korea has mobilized young construction workers to build homes in North Pyongan Province's flood-affected areas.

Kim Jong Un Sends Love Letter to Putin on Russia Day

Kim Jong Un congratulates Putin on Russia Day, pledging to strengthen the "unbreakable" partnership between North Korea and Russia.

Tag: Patent

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

SCL Healthcare secures patent for technology predicting metabolic syndrome using 3cc of blood

SCL Healthcare has patented a DNA methylation technology to predict metabolic syndrome risk, enhancing disease diagnosis from blood samples.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

Rokit Healthcare’s Groundbreaking Kidney Regeneration Patent: What It Means for Patients and the Market

Rokit Healthcare secures a U.S. patent for kidney regeneration, aiming to revolutionize treatment and collaboration with Harvard Medical School.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

Rokit Healthcare Secures UAE Patent for AI-Based Cartilage Regeneration: A Game-Changer in Middle Eastern Joint Treatment

Rokit Healthcare secures a UAE patent for AI cartilage regeneration, targeting a $682M market and shifting focus to regenerative medicine.

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Celltrion’s Eydenzelt: How Strategic Patent Agreements Enable U.S. and European Market Entry in 2026

Celltrion's Eydenzelt secures global distribution via strategic patent agreements, aiming for swift market entry in the U.S. and Europe.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.